Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Related Posts
Job openings jumped and hiring slumped in October, key labor report for the Fed shows
Job openings totaled 7.74 million on the month, up 372,000 from September.
New Boeing CEO sets sights on ‘leaner’ future as quarterly loss tops $6 billion
Boeing had released preliminary results earlier this month showing a big loss and $5 billion in charges across its defense and commercial units.
Traders betting Fed will cut rates at least 4 times this year to bail out economy
Data from the CME Group on Friday showed raised odds the federal funds rate will fall to 3.00% to 3.25%, down from 4.25% to 4.50% […]